missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse IL-28B/IFN-lambda 3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 1789-ML-025
Additional Details : Weight : 0.00970kg
Description
Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.800-8.00 ng/mL.Specifications
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
19.7 kDa | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. | |
Unconjugated | |
Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
338374 | |
IL-28B/IFN-lambda 3 | |
E. coli-derived mouse IL-28B/IFN-lambda 3 protein Asp20-Val193,with an N-terminal Met | |
<0.10 EU per 1μg of the protein by the LAL method. | |
Recombinant | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |